Multiple Sclerosis And Related Disorders

雜志介紹

Multiple Sclerosis And Related Disorders雜志介紹

《Multiple Sclerosis And Related Disorders》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱多發(fā)性硬化癥及相關(guān)疾病，本刊主要出版、報(bào)道醫(yī)學(xué)-CLINICAL NEUROLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.9，最新CiteScore 指數(shù)為5.8。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey

  Author: Liu, Xu; Guo, Kundian; Lu, Lu; Luo, Rong; Liu, Jie; Zhou, Dong; Hong, Zhen

• Significant retinal microvascular impairments in multiple sclerosis assessed through optical coherence tomography angiography

  Author: Wang, Xuejiao; Wang, Xuqian; Chou, Yuyu; Ma, Jin; Zhong, Yong

• Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder

  Author: Yuan, Congcong; Liu, Xueyu; Cai, Shuang; Zhang, Lu; Guo, Ruoyi; Jia, Zhen; Sun, Yafei; Li, Bin

• Differentiation of MOGAD in ADEM-like presentation children based on FLAIR MRI features

  Author: Wei, Shaonong; Xu, Lu; Zhou, Deyang; Wang, Tianlei; Liu, Kezhou; Gao, Feng; Cao, Jiuwen

英文介紹

Multiple Sclerosis And Related Disorders雜志英文介紹

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.

A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.